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Posttranslational modifications (PTMs) of proteins represent fascinating extensions of the dynamic complexity 
of living cells’ proteomes. The results of enzymatically catalyzed or spontaneous chemical reactions, PTMs form 
a fourth tier in the gene – transcript – protein cascade, and contribute not only to proteins’ biological functions,
but also to challenges in their analysis. There have been tremendous advances in proteomics during the last 
decade. Identification and mapping of PTMs in proteins have improved dramatically, mainly due to constant 
increases in the sensitivity, speed, accuracy and resolution of mass spectrometry (MS). However, it is also 
becoming increasingly evident that simple gel-free shotgun MS profiling is unlikely to suffice for comprehensive 
detection and characterization of proteins and/or protein modifications present in low amounts. Here, we review 
current approaches for enriching and separating posttranslationally modified proteins, and their MS-independent 
detection. First, we discuss general approaches for proteome separation, fractionation and enrichment. We then 
consider the commonest forms of PTMs (phosphorylation, glycosylation and glycation, lipidation, methylation, 
acetylation, deamidation, ubiquitination and various redox modifications), and the best available methods for 
detecting and purifying proteins carrying these PTMs. 
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1. Introduction  
1.1. So few, and yet so many 
Proteomes are expected to be two to three orders of magnitude more complex than would be predicted from 
numbers of protein-encoding genes present in the respective genomes. There are over 300 known naturally 
occurring amino acids, but only 64 codons in the genetic code and the actual number of proteinogenic amino 
acids is even lower. Altogether, 22 amino acids have been proven to be encoded by DNA. However, after protein 
translation these amino acids may undergo further modifications, which considerably increase the diversity of 
proteins present in living cells. These modifications can be either transient or permanent, and may result from 
either targeted, enzymatically catalyzed reactions or spontaneous chemical reactions in the cell. The Unimod 
Database (http://www.unimod.org; 10/2012) lists almost 1000 different protein modifications that have been 
detected in mass spectrometric analyses of proteins, but some of them could be artifactual, like methionine and 
cysteine oxidations during two-dimensional electrophoresis (2-DE), carbamylation by urea on any free amino 
group in the protein sample (at N-termini, or side chains of arginine or lysine), and modifications introduced by 
MS analysis (e.g. conversion of phosphoserine to dehydroalanine with neutral loss of phosphoric acid). The 
RESID database hosted by the European Bioinformatics Institute, EBI (http://www.ebi.ac.uk/RESID/; 10/2012), 
compiles information on protein posttranslational modifications (PTMs) found in nature and its release 70.01 
(08/2012) lists 591 entries. Covalent protein modifications can be classified as a covalent addition of some 
chemical group, or a covalent cleavage of peptide backbones [1]. Side chain modifications are known for all of 
the proteinogenic amino acids except Ala and Pyr, and all can undergo crosslink reactions and/or N- or C-
modification if they are at the N- or C-terminus, respectively, of their respective proteins (Fig. 1). 
 
<-Figure 1-> 
2. Methods applied in PTM analyses 
2.2. Protein separation or “Thou shalt not use only bottom-up proteomic approaches” 
Widely used MS-based approaches in so-called “bottom-up proteomics” (involving digesting samples by 
selected proteases, MS analysis of the resulting peptides and finally assembly of the identified sequences) are 
excellent for high-throughput protein identification. However, some information is generally lost when proteins 
are cleaved into fragments by the chosen proteases prior to MS analysis in typical protocols. Due to the vast 
ranges of concentrations of proteins in cells and differences in ionization potentials of peptides, it is always 
challenging to obtain full sequence coverage, and even then it is very difficult to distinguish peptides from partly 
cleaved protein isoforms. Thus, in bottom-up approaches some of the diversity of isoforms that may result from 
a single initially translated protein is inevitably lost (Fig. 2). However, a PTM generally changes a protein’s 
chemical and physical characteristics (e.g. molecular weight, shape, charge, pI, hydrophobicity and interactions 
with other proteins or ligands). Thus, proteins carrying PTMs can be separated, and the PTMs can be identified, 
mapped and characterized by using techniques that exploit these changes. 
 
<-Figure 2->[2] 
 
2.2.1. Size does matter 
Protein PTM by a cleavage may result from autocatalytic activity, protease-mediated regulation, or non-
enzymatic protein damage [3]. This is theoretically the easiest kind of PTM to detect, because the average 
molecular weight of an amino acid residue is 110 Da [4], hence losses of one or more can be readily detected by 
methods separating proteins according to their mass. Apart from mass spectrometry and gradient 
ultracentrifugation, there are two suitable techniques for estimating the mass of a protein and separating cleaved 
protein isoforms. The first is size-exclusion chromatography (SEC), also called gel filtration. In SEC samples are 
introduced in solution to a column containing a solid phase consisting of cross-linked polymer beads with pores 
or cavities that large proteins cannot enter. Thus, they pass rapidly through the column around the beads. In 
contrast, smaller proteins are retarded to size-related degrees. This technique can fractionate proteins covering a 
wide mass range (0.1-100 kDa), depending on the pores’ size [5]. The second option is polyacrylamide gel 
electrophoretic separation in the presence of the denaturant sodium dodecyl sulfate (SDS-PAGE). 
Approximately one SDS molecule binds per two amino acids, which masks the native charge of a protein and the 
resulting negative net charge is proportional to the protein’s mass. During the electrophoresis, the gel acts as a 
molecular sieve so the rate of migration of proteins in a sample is inversely related to their mass (high molecular 
weight proteins are retarded more than smaller proteins). The original setup presented by Laemmli [6] is not 
suitable for separating low molecular weight proteins (<10 kDa), but there are modifications which overcome 
this limit [7]. The resolution of both separation techniques allows the estimation of a protein’s molecular mass 
with kDa precision, which means that a loss of ten amino acid residues results in a detectable shift in a protein’s 
mobility. However, while a protein’s mobility may be mainly dependent on its mass, shifts may be also due to 
intramolecular changes. For example, protein phosphorylation can induce calcium ion binding, which reduces 
SDS-PAGE mobility [8]. 
 
2.2.2. Isoelectric focusing 
During isoelectric focusing (IEF), charged proteins migrate through a pH gradient. The net charge of a protein is 
the sum of all the negative or positive charges of the amino acid side chains, which depends on the pH 
environment and is zero at the protein’s isoelectric point (pI). Thus, electrophoretic migration of a protein stops 
at its pI and all proteins are focused around their respective pI. This is only possible when the three-dimensional 
protein structure is disrupted by chaotropic agents such as urea, and all charged residues are exposed to the 
medium. Basic and acidic amino acid residues that contribute to a protein’s net charge are often sites of PTMs, 
and the PTMs often change their charge. For example, acetylation masks positive charge of lysine residues, 
while phosphorylation or deamidation introduces an additional negative charge to a protein. Thus, PTMs are 
reflected in changes in a protein’s pI and can be detected by IEF. In addition to gel-based IEF, which is suitable 
for analytical studies (see 2-DE), IEF can also be applied in preparative mode. Liquid-phase IEF can be used in 
preparative analyses, or for separating protein samples into fractions over a specific pI range. This technique has 
lower resolution than gel-based IEF and suffers from pH drifts, but it can separate membrane and hydrophobic 
proteins, as well as large protein complexes [9]. Off-gel electrophoresis, combining gel and liquid phase modes, 
provides better performance than liquid-phase IEF, but transferring samples from the gel to the liquid phase can 
be problematic [10]. Another option is “free flow” electrophoresis, which can also be applied in IEF mode. The 
method originally developed by Hannig [11] separates protein samples within a thin film of electrolyte that flows 
laminarly between two parallel cooling plates. After an electric field is applied (perpendicular to the flow), 
proteins are deflected from the direct flow based on their charge and separated into fractions.    
 
2.2.3. Two-dimensional electrophoresis (2-DE) 
Two-dimensional gel electrophoresis has been one of the most successful methods for detecting and analyzing 
protein PTMs. The method introduced in 1975 [12, 13] combines an IEF separation in the first dimension and an 
SDS-PAGE separation in the second dimension. A gel with proteins focused by IEF is treated with SDS to cover 
their native charges, then SDS-PAGE is applied to separate them on the basis of their molecular weights in a 
plane perpendicular to the plane of the first separation (Fig. 3, A). The reproducibility of 2-DE depends largely 
on the IEF step and has been significantly improved by using an immobilizing pH gradient [14]. Theoretically, 
2-DE offers unsurpassed resolution and a standard large gel (~ 20 × 20 cm) should be able to resolve over 10,000 
protein spots. In practice, a protein present in amounts below 0.5 ng is difficult to detect, even with the most 
sensitive detection stains (silver or fluorescent total-protein stains) and the detection limit of the widely used 
colloidal Coomassie dye is around 10 ng [7]. Further, PTMs increase the number of spots originating from a 
single protein, thus quantitative 2-DE analysis is usually restricted to sets of at most a few thousand proteins. 
The greatest potential of 2-DE is in qualitative analysis. The change in the mass of a protein due to a PTM is 
often too small to be easily detected by standard SDS-PAGE. However, many PTMs introduce charged groups 
into the protein, which leads to a detectable change in the position of the protein on a 2D gel. It has been shown 
that IEF in narrow pH ranges can separate proteins that differ in pI values by just 0.001 to 0.01 pH units [15]. In 
addition, comparisons of theoretical and observed protein pI and molecular masses can indicate spliced isoforms 
as well as proteins with PTMs (Fig. 3, B). Modified proteins can also be visualized in-gel or after Western 
blotting using specific stains or antibodies, which are available for all major PTMs. However, in addition to the 
scale limitation mentioned above, 2-DE approaches have several drawbacks. One is that they require roughly 
100-fold larger samples than routine LC-MS analysis. A second problem lies in the IEF step. Hydrophobic 
proteins, large proteins (> 150 kDa), and proteins with extreme pI values cannot easily enter the gel and may be 
lost during this step. Furthermore, very small proteins can be washed away during protein equilibration with 
SDS. It is also very important to run IEF at an appropriate temperature, generally around 20 °C, otherwise the 
presence of urea may lead to artificial carbamylation modification of the proteins in the sample. The presence of 
excessive amounts of salts and buffer ions in the sample can also cause sharp temperature rises, which can 
promote carbamylation reactions, or even in extreme cases burn the gel strip. Further, IEF is time-consuming and 
some proteins may become unstable when focused too long, e.g. cysteine residues may be oxidized [16]. The 
problems associated with separating membrane proteins and proteins with extreme pI values can be 
circumvented by replacing IEF with blue native (BN) PAGE [17], in which proteins in a sample interact with 
Coomassie brilliant blue G-250 dye before their separation. Binding of the dye results in a negative surface 
charge, which is essential for electrophoretic separation, but does not denature proteins so their migration (and 
separation) is influenced not only by their mass (as in SDS-PAGE), but also by their net surface and molecular 
shape.  
 
2.2.4. Liquid chromatography (LC) 
Analysis by 2-DE is time consuming. The lack of automation and the necessity to extract proteins prior to MS 
analysis led to the development of alternative methods based on liquid chromatography. A two-dimensional 
column-based liquid chromatographic technique for resolving complex mixtures was initially introduced in 1978 
[18], but its first application in proteomics dates to 1990 [19]. Since then the methodology has been further 
improved and accelerated. For example, while a separation by the original set-up took six hours, the method 
presented by Stoll et al., (2006) requires only 30 min and provides ca. 100-fold improvement in peak capacity 
(the number of peaks/protein species that can be separated from one another)[20]. In standard 2D-LC proteomic 
separation (Fig. 3, C), proteins are separated according to their charge in the first dimension, much like IEF, 
except that the pI axis is in bands instead of continuous pI increments. This is done by chromatofocusing, which 
replaced previously used ion-exchange columns (e.g. strong cation exchange – SCX columns). A pH gradient is 
created as the eluting buffer, composed of a large number of buffering substances (polybuffer), titrates a weak 
anion exchanger chromatography medium. The protein with the highest pI elutes first and no protein is thus 
exposed to a higher pH than its own pI. In contrast to IEF, this method can separate large proteins and 
hydrophobic proteins, as well as smaller and hydrophilic proteins [21]. Reversed-phase liquid chromatography is 
usually used for the second dimension separation, which separates the proteins by hydrophobicity. There are 
numerous possible combinations of LC techniques and theoretically they could all be combined for 
multidimensional separation. In practice, mobile phase compatibility restricts the number of on-line modes that 
are suitable for proteomic analysis. The compatibility restrictions can be lessen by employment of an off-line 
setup in which collected fractions can be either concentrated by evaporating the buffer or diluted prior to 
separation in the following dimension [22]. However, only a few successful examples of this approach have been 
reported. The combination of chromatofocusing and size-exclusion chromatography is, in principle, similar to 2-
DE separation, but it only provides comparable resolution over pH intervals of 3 pH units or less. Like 2-DE, 
multidimensional chromatography is capable of separating proteins carrying PTMs (e.g. [23]). However, it has 
been more commonly used for peptide fractionation prior to MS analysis, because there is no available technique 
for visualizing specific PTMs separated by multidimensional chromatography (unless affinity chromatography 
can be used) that provides comparable sensitivity and resolution to gel staining or Western blotting.    
 
2.2.5. Diagonal separation 
In the earliest examples of diagonal separation paper electrophoresis was used to characterize disulfide bonds in 
peptides[24]. Briefly, mixtures of proteins were separated on a paper strip, treated with performic acid to break 
disulfide bonds by oxidizing cysteine residues to cysteic acid, and then subjected to a second dimension 
separation. Peptides that had identical electrophoretic mobility lay along a diagonal line following the two-
dimensional separation, while peptides whose disulfide bonds were disrupted lay off the diagonal. This method 
was later adapted for separating intact proteins in polyacrylamide gels [25], using a similar protocol to 2-DE 
expect that the first-dimension gels are also SDS-denaturing (Fig. 3, D). After separation, proteins containing no 
interpolypeptide disulfide bond(s) lie in a diagonal line, whereas disulfide-linked protein complexes are 
separated into individual components and resolved below the diagonal. The reduction of intrachain disulfide 
bonds retards migration in the second dimension and the resulting protein spots appear above the diagonal [26]. 
Diagonal separation has also been extended to LC applications, which are most suitable for analyzing peptides 
with PTMs, but can also be adapted for proteins with PTMs. In a typical experiment, a sample is fractionated by 
HPLC, fractions are collected, dried, treated to modify a residue or PTM and again subjected to HPLC analysis. 
This technique has been used to study modifications including phosphorylation, nitration and N-glycosylation 
[27-30]. The latest development in this field is an automated enzyme-based approach involving capillary 
electrophoresis, in which the distal end of the first capillary incorporates an enzyme-based microreactor [31]. 
Obviously, it is currently designed to detect modified peptides, because the immobilized enzyme requires 
unhindered access to the site of the PTM, but it shows promising potential for further development.  
   
<-Figure 3-> 
2.2.6. Affinity separation and enrichment     
The separation of proteins by means of the electrophoresis or chromatographic methods described in the 
previous section is based on their mass, charge or hydrophobicity. Thus, protein PTMs can be detected by the 
shift in net mass/charge/hydrophobicity they introduce to the modified protein. This approach is excellent if a 
PTM is not known, the proteins of interest are abundant, or if there is no available enrichment technique. In other 
cases, enrichment is highly advisable, and the main available enrichment techniques are described below. 
   
2.2.6.1. Immunoaffinity 
PTM-specific antibodies can be raised against virtually any protein that can be purified. The Human Protein 
Atlas Project has provided a massive array of antibodies, covering target proteins encoded by over 14,000 human 
genes (http://www.proteinatlas.org/;10/2012). However, it is difficult to obtain specific antibodies targeting only 
a PTM group and no other protein epitopes, although this problem can be circumvented (to some degree) by 
raising antibodies against synthetic peptides bearing PTMs or artificial substances that mimic the structure of a 
targeted PTM [32]. Well-designed anti-peptide antibodies provide much (but not all, as discussed below) of the 
specificity required for purifying protein families, e.g. substrates of a specific kinase [33]. Commercially 
available antibodies cover several PTMs, including phosphorylation, acetylation, glycosylation, myristoylation, 
prenylation, sumoylation and ubiquitination. They are generally either cross-linked to a resin or labeled with a 
tag that facilitates their retrieval after a modified protein is captured and they can be used for either 
immunoprecipitation or in immunoaffinity columns. For example, proteins with N-trimethylated lysine residues 
can be purified by biotinylated antibodies (e.g. ImmuneChem; http://www.immunechem.com). 
 
2.2.6.2. Ligand affinity enrichment 
Some PTMs have an affinity for metal or inorganic ions. For example, immobilized Ga ions can separate 
sulfated peptides [34] and several combinations of metal ions and metal oxides are widely used for 
phosphoproteome analysis (see 3.1.2.). Naturally occurring PTMs often participate in cell signaling and protein-
protein interactions. Thus, it is also possible to employ innate protein-ligand interaction systems to bind 
modified proteins, notably lectin-based affinity columns for glycoproteome enrichment, and media incorporating 
a ubiquitin-binding domain for ubiquitinome analyses (see respective parts of this review). 
  
2.2.6.3. Derivatization 
In cases where there is no suitable affinity enrichment technique, a PTM can sometimes be labeled with a tag in 
vivo, using the native cellular machinery to incorporate modified biomolecules such as tagged carbohydrates or 
lipids [35]. In more elaborate approaches for in vitro tagging, purified recombinant enzymes or chemoselective 
reactions can be used. Introduced labels can serve for detection (e.g. fluorophores) or isolation, usually via 
biotin-avidin affinity enrichment of biotin-tagged proteins/peptides. The purity of enriched PTM proteins can be 
further increased by including a cleavable linker in biotin tags, thus allowing bound proteins to be released 
without risking contamination by natively biotinylated proteins or a need for harsh denaturing conditions that 
may lead to the elution of non-selectively bound proteins [36]. Chemical tagging procedures are available for all 
major PTMs, including acetylation, acylation, prenylation, phosphorylation and gylcosylation ([35] and 
references therein). 
 
2.3. Deeper mining to detect hidden proteins and PTMs 
The past decade has seen huge advances in proteomics. There is no doubt that this is mainly thanks to interest in 
the human proteome and its apparent potential for medical applications, but all sectors of proteomics are rapidly 
advancing. For example, there were less than 1000 experimentally identified gene products of the model plant 
Arabidopsis thaliana in 2004 [37], but the Arabidopsis proteome pep2pro database now includes proteomic data 
for over 14 500 proteins (excluding proteins with only single hits) (http://fgcz-pep2pro.uzh.ch; [38]). Ordinary 
proteomic experiments based on 2-DE and liquid chromatography do not usually cover more than a fifth of this 
number, and it is estimated that alternative splicing and PTMs increase the number of different proteins to at 
least 100 000. Thus, the most comprehensive studies, covering several thousands of identified proteins, are only 
scratching the surface of the whole proteome. This is partly due to the presence of several highly abundant 
proteins, which interfere with the detection of less abundant proteins. Examples include: collagen, actin, myosin 
and keratin in many animal tissue samples; albumin, which accounts for up to 60 % of plasma proteomes; and 
RuBisCO, which may account for more than 40 % of the protein content in some plant tissues [39]. In marked 
contrast, proteins and many PTMs are frequently below the sensitivity threshold of available analytical methods, 
and this problem cannot (generally) be solved by crude fractionation, tissue sampling or organelle purification.  
 
2.3.1. Immunoaffinity depletion 
Several approaches are used to deplete abundant proteins in samples and increase the proteome coverage. The 
first option is to use immunoaffinity separation. Commercially available kits offer immunoaffinity partitioning of 
highly-abundant proteins, for example from plasma/serum proteomes, with antibodies for up to 20 proteins. 
Further, moderately abundant proteins can be further depleted by antibodies obtained from immunizing chickens 
with plasma proteins from which the highly-abundant proteins have been removed. This two-step procedure 
theoretically provides a fraction of low-abundance proteins (in the flow-through) and one of moderately 
abundant proteins (in the eluted fraction) [40]. Of course, this approach has limits and the price of mixed 
antibody columns is quite considerable.  
 
2.3.2. Proteome equalization 
The second widely used option is based on peptide affinity subtraction. This technique has been in development 
for over two decades, the first reports dating back to the early 1990s [41]. Its commercialized versions employ a 
bead-based combinatorial peptide ligand library (CPLL), each unique ligand theoretically binding a unique 
protein epitope. In theory, when a complex biological sample is applied to the beads, highly abundant proteins 
saturate their high-affinity ligand or ligands, and excess protein is washed away. In contrast, low-abundance 
proteins are concentrated on their specific affinity ligand or ligands. The major targets of peptide affinity 
subtraction are plasma and serum proteomes, but it can be used to reduce the dynamic range of proteomes from 
any complex biological samples [39, 42]. It provides a relatively cheap alternative to immunoaffinity separation 
that has several advantages, including cross-sample/species applications. The decomposition of affinity beads 
also poses much minimal risks of sample contamination, unlike antibody degradation. Furthermore, samples can 
be further divided by sequential elution [43]. On the other hand, results of CPLL extractions depend on protein-
ligand affinity interactions and are highly unpredictable. Jiang et al. (2010) have even presented indications that 
this method does not improve the quantitative results of proteomic analyses [44], but this may have been due to 
their use of a gel-free approach, because we have found that 2-DE benefits from a CPLL application (Fig. 4).  
 
<-Figure 4->[45] 
3. Major protein PTMs found in proteomic studies 
Many protein modifications have a significant physiological/biological impact. Both enzymatic and non-
enzymatic (chemical) PTMs occur, and with limited knowledge of their origins it is difficult to correctly 
distinguish their nature. Historically, the most thoroughly studied type of PTM is phosphorylation, largely due to 
the relative ease of detecting protein O-phosphorylation in vivo and in vitro. While the enzymatic origin of O-
phosphorylation was soon accepted, N-phosphorylation was long considered an experimental artifact or a 
product of non-enzymatic activity. The existence of N-kinases was recognized much later [46, 47], and the 
possibility that this kind of PTM could occur spontaneously has still not been ruled out. A similar controversy 
surrounds other PTMs, for example protein S-ubiquitination, which is also considered to be non-enzymatic [48]. 
We are still far from fully understanding functions of individual gene products and it is likely that future 
discoveries will lead to the reevaluation of enzymatic and non-enzymatic PTMs. Some PTMs are clearly results 
of protein ageing, especially in proteins that are slowly metabolized, and thus are exposed for longer times to 
reactive endo- and exogenous compounds. However, following discovery of the role of oxidative damage in cell 
signaling, it is tempting to speculate that at least some of these modifications could be of enzymatic origin, even 
if it is through an indirect effect of metabolite production and channeling. In the following text we summarize 
techniques for detecting and enriching protein PTMs, focusing on their applicability for large-scale proteomic 
analysis. The selected PTMs (Fig. 5) represent not only the most commonly studied protein modifications, with 
numbers of entries in the UniProt database [49] reaching up to 10 % of all proteins currently reviewed by its host 
consortium, but each presents specific problems, and requires an appropriately adjusted proteomics approach for 
detection and enrichment. We do not strictly separate PTMs usually classified as enzymatic from non-enzymatic 
PTMs, partly because the methodology for a given type of PTM is easily transferable and partly because a non-
enzymatic modification may result in loss of an enzymatic PTM, as believed e.g. for N-phosphate 
dephosphorylation or protein demethylation (see respective parts of the review). 
 
<-Figure 5->[50, 51] 
 
3.1 The phosphoproteome 
In 1906 Leven and Alsberg discovered phosphorylation of the egg yolk protein vitellin. It took nearly 30 years to 
track down this phosphorylation to serine residues and a further 20 years to discover that it is actively catalyzed 
by enzymes [52]. Today, protein phosphorylation is probably the most intensively studied PTM. Numerous 
studies have demonstrated that reversible phosphorylation is a key posttranslational modification, and is 
involved in nearly all cell processes. It has been shown to participate in signaling and the regulation of diverse 
enzyme activities, protein-protein interactions and protein targeting (e.g. [53-58]). Loss of phosphorylation is 
also known to render some proteins susceptible to degradation, thus regulating their lifespans [59, 60]. The aim 
of so-called phosphoproteomics is to study protein phosphorylation by identifying phosphoproteins, quantifying 
phosphorylation, precisely mapping phosphorylation sites, and ultimately revealing their biological functions 
[61]. Potential phosphorylation sites are estimated to be approximately three times more numerous than genes 
and a third of expressed proteins are assumed to be phosphorylated at any given time. The largest study of the 
humans phosphoproteome detected 20 443 phosphosites, and the Arabidopsis phosphoprotein database 
PhosPhAt (http://phosphat.mpimp-golm.mpg.de; 10/2012; [62]) lists 12 613 unique phosphosites in 5663 
phosphoproteins.  Regulation of such extensive and dynamic phosphorylation states requires about 3 % of 
human genes and 5 % of the genes in Arabidopsis thaliana, encoding about 1100 protein kinases and 100 to 200 
protein phosphatases [63]. Eight amino acids can be phosphorylated (Fig. 5, A), but in eukaryotic cells, protein 
kinases and phosphatases are believed to act mainly on Ser, Thr and Tyr residues, typically resulting in 
pSer/pThr/pTyr ratios of ca. 1800/200/1. The stability of phosphorylation at the other amino acids is lower. 
Phosphoramidates, i.e. phosphohistidine, phosphoarginine and phospholysine, mostly go undetected in 
conventional studies of protein phosphorylation because of the instability of the phosphate-nitrogen bond in 
acidic solutions [64, 65]. However, reversible His phosphorylation is estimated to occur in a pHis/pTyr ratio of 
10/1-100/1 [63]. The stability of acyl-phosphates is even lower, but they play a role for instance in signaling 
pathways. While protein phosphorylation is considered to be solely catalyzed by enzymes, protein 
dephosphorylation may be either enzymatic or non-enzymatic, and the latter may be simply related to protein 
ageing. However, losses of phosphorylations, especially temperature and pH-labile phosphorylations, is also 
considered to participate in fast intrinsic responses to stimuli [64].  
3.1.1. Visualization of phosphorylated proteins 
Radioisotopes have been used since the beginning of phosphorylation research and experiments with 
radiolabelled ATP have confirmed that protein phosphorylation is catalyzed by enzymes. This previously widely 
used method is based on use of [32P] labeled -ATP as a substrate for in vitro kinase reactions followed by 
separation of labeled phosphorylated peptides by thin layer chromatography (TLC). Many phosphoproteins can 
be visualized by autoradiography, but they are not usually present in sufficient amounts to be identified [52, 66]. 
In addition, radiolabeling in vivo is problematic and cannot be used to follow natural phosphoproteome 
dynamics. Legal and safety restrictions further limit the use of radiolabeled substances and this methodology is 
currently in decline, being replaced by immunodetection or fluorescent staining. Increasing numbers of 
commercially available antibodies can be used for phosphoprotein detection in Western blot analysis (suppliers 
include Qiagen (http://www.qiagen.com), Santa Cruz Biotechnology (http://www.scbt.com/) and Life 
Technologies (http://www. lifetechnologies.com). Their use suffers from all disadvantages of antibody-based 
methods, i.e. they are rather expensive and have questionable specificity. Further, anti-phospo-PTM antibodies 
are only currently available for pTyr, pSer and pThr. The first fluorescent stain that allowed direct, in-gel 
detection of phosphate groups attached to tyrosine, serine, or threonine residues (without the need for antibodies 
or radioisotopes) was Pro-Q Diamond (Life Technologies). It can be used to label proteins in standard SDS-
polyacrylamide gels or 2-D gels and the staining procedure has been optimized [67]. The second florescent dye 
is based on Phos-tag (http://www.phos-tag.com/; [68]), an alkoxide-bridged dinuclear metal (usually Zn2+ and 
Mn2+) complex. These tags preferentially capture phosphomonoester dianions bound to Ser, Thr and Tyr 
residues. The detection is based either on a mobility shift of phosphorylated proteins in SDS-PAGE 
(polyacrylamide-bound tags) or tag-reporter conjugates [61, 69]. The fluorescent Phos-tag™ Phosphoprotein Gel 
Stain produced by Perkin Elmer (www.perkinelmer.com) exploited this technique, but it is no longer available. 
The only Phos-tag based detection kit currently on the market is a biotin-tagged version for Western blotting, 
Wako Pure Chemical Industries (http://www.wako-chem.co.jp). These phosphospecific stains have certified 
ability to detect pThr, pSer and pTyr, but can also detect pAsp  and N-phosphates [70]. The detection limit of 
florescent stains is reportedly 1-16 ng of phosphoprotein; 5-20× the sensitivity of techniques based on chemical 
derivatizations, e.g. by the GelCode Phosphoprotein Staining Kit (Pierce, www.piercenet.com). Phosphospecific 
stainings share several of the disadvantages of phospho-specific antibodies: their prices are high and their 
specificity must be usually validated by normalization to a negative control. Furthermore, phosphorylation in 
proteins detected by phosphostaining is often not detectable by MS analysis, indicating that the stains yield false 
positives, although this could be at least partly due to their ability to mark labile N-phosphates, which escape 
detection by conventional approaches [65]. 
 
3.1.2. Phosphoproteome enrichment by affinity chromatography 
The method of choice for identifying phosphorylation site is mass spectrometry, which has replaced Edman 
degradation. However, the abundance of many signaling proteins is low in cells (even relative to the attomolar 
sensitivity of modern MS systems), and the proportions of these proteins that are phosphorylated at any given 
time may also be quite low. Therefore, in a standard LC-MS/MS experiment, the chance of detecting and 
sequencing many phosphopeptides is quite low [52]. A number of methods to enrich the phosphorylated fraction 
in samples and thus overcome these problems have been developed. Immobilized metal ion affinity 
chromatography (IMAC) was originally introduced, in 1975, for purifying native proteins with an intrinsic 
affinity for metal ions [71] and was focused on isolating His-tagged proteins. The ability of phosphoserine (in 
phosphorylated ovalbumin) to bind selectively to immobilized iron was demonstrated in 1986 [72]. This is based 
on the affinity of the negatively charged phosphate group for metal ions (usually Fe3+ or Ga3+), but they co-
chelate proteins with surface histidines, cysteines or tryptophans. Bound proteins are eluted by introducing 
excess free ligand (phosphate buffer), or by raising the pH (e.g. by adding NH4OH), which promotes their 
dissociation from the IMAC matrix. Non-specific binding of acidic proteins and peptides to the IMAC matrix 
can be partly circumvented by chemical derivatization of the sample (esterification of carboxyl groups) or adding 
acetate to the sample. Metal oxide affinity chromatography (MOAC) was introduced for analyzing 
phosphorylated substances in 1990 [73] and is currently the technique of choice for enriching phosphopeptides 
resulting from the tryptic digestion of phosphoproteins prior to MS analysis. Two kinds of beads are commonly 
used: ZrO2 and TiO2, which reportedly have specificity (or at least some selectivity) for singly- and multi-
phosphorylated peptides, respectively [74]. This methodology has been well optimized (see e.g. [75]), but it is 
not frequently used for intact proteins. Aluminum hydroxide (Al(OH)3) matrices have also been used for MOAC 
phosphoprotein enrichment. These matrices are relatively inexpensive and provide comparable yields to those 
obtained using commercial phosphoprotein purification kits [76]. The numbers of IMAC- and MOAC-based 
methods are constantly increasing. For example, Ti4+-IMAC and Polymer-based metal ion affinity capture 
(PolyMAC) techniques have been reported, both of which exploit the titanium atom’s ability to bind 
phosphopeptides [77, 78]. Commercial kits with single-use columns and buffers are also now available to 
explore the broadening avenues of phosphoproteomics. The manufacturers do not describe the composition of 
the affinity matrices in their kits, except those based on affinity to phosphospecific dyes (Phos-tag agarose, 
Wako; Pro-Q Diamond Phosphoprotein Enrichment Kit, Life Technologies). However, the similarity of 
purification results obtained using these kits to those obtained using IMAC/MOAC matrices (e.g. [76]) suggests 
that they are also probably based on IMAC/MOAC technology. Chromatofocusing and ion exchange 
chromatography are options that can be used to selectively enrich acidic proteins from a sample. As 
phosphoproteins are generally acidic, these methods can be used for crude fractionation of proteomes. Even 
separating differentially phosphorylated protein isoforms is possible, provided the samples are not too complex 
[21]. The last phosphoprotein-enrichment method that should be mentioned is hydroxyapatite chromatography; a 
type of “pseudo-affinity” chromatography or “mixed-mode” ion exchange using a form of calcium phosphate 
with the formula Ca10(PO4)6(OH)2. Several types of hydroxyapatite resins have been designed for protein and 
DNA separation. Hydroxyapatite has high loading capacity and proteins are eluted by increasing the 
concentration of phosphate in the elution buffer. This form of chromatography is also not entirely 
phosphoprotein-specific, as the carboxyl moieties of protein interact with the resin in a similar way (albeit more 
weakly) to phosphoresidues, but it has been frequently applied for separating proteins that differ only in their 
phosphorylation (e.g. [54]). 
 
3.1.3. Uses of antibodies and derivatization in phosphoproteome analyses 
Antibodies raised against phosphorylated peptide sequences can be used to immunoprecipitate targeted 
phosphoproteins from a cell lysate. Phosphotyrosine antibodies have been available for several years, and 
pSer/pThr antibodies are also commercially available, but they reportedly have lower specificity [79]. Producing 
anti-phosphohistidine or antiphosphoaspartate antibodies is problematic due to instability of these 
phosphorylations. However, many commercially available anti-phosphotyrosine Ig antibodies also recognize 
phosphohistidine [64]. Immunoprecipitation is unsuitable for large-scale phosphoproteome studies as several 
parallel immunoprecipitation reactions are required for each phosphoamino acid, but it can be beneficial if 
specific phospho-site enrichment is desired [80]. Several derivatization-based phosphoprotein enrichment 
methods have been developed, but they involve several chemical reactions that are not 100 % efficient. Thus, 
yields are limited. Further, their specificity is also questionable. For example, replacement of phosphate groups 
with biotinylated tags [81] does not work with pTyr, but can modify Ser/Thr O-glycosylated forms or even non-
modified residues [82]. Due to the uncertainty of reaction specificity, the wider spread of derivatization-based 
techniques for phosphoproteome analyses seems unlikely.  
 
3.1.4. The future of phosphoproteomics 
The plethora of methods available for isolating phosphoproteomes does not simplify the task. Many studies 
indicate that different approaches provide complementary rather than overlapping coverage of captured 
phosphoproteins/peptides. Further, labile phosphorylations cannot be robustly identified, mapped and 
characterized using current methodology. Only time will tell which techniques, combinations of approaches or 
novel procedures will prevail. A promising approach seems to be an automated diagonal capillary 
electrophoresis technique based on use of immobilized phosphatase, which has demonstrated utility for handling 
a mixture of phosphopeptides [31]. A similar approach could be theoretically extended to phosphoprotein 
samples. Of course, the susceptibility of individual phosphoproteins to the phosphatases applied and increased 
sample complexity would be limiting factors. Today, the best enrichment approach for large-scale 
phosphoproteome studies seems to be a two-step procedure, starting with phosphoprotein enrichment (using 
aluminum hydroxide chromatography, for example) followed by digestion and subsequent phosphopeptide 
enrichment using IMAC or MOAC resins [83]. 
 
3.2. Redox proteomics 
Numerous posttranslational modifications are caused by chemically reactive species such as reactive oxygen and 
nitrogen species (ROS/RNS) that are produced via cellular activities (especially, but not solely, under “oxidative 
stress conditions”, when the reductive capacity of the cell’s antioxidant systems is exceeded), and are capable of 
damaging proteins, lipids, carbohydrates and nucleic acids. The reactions involved may be purely non-
enzymatic, e.g. in uncontrolled responses to excessive energy absorption during photosynthesis, but reactive 
species can also be generated to damaging levels in processes linked to physiological cell defense and signaling 
processes [84, 85]. Proteins are considered to be major targets of the oxidative species, accounting for 68 % of 
oxidized molecules in the cell [86]. Oxidative protein modifications may be either reversible or irreversible, and 
may result from either direct oxidation of amino acid residues or the formation of reactive intermediates. Thiol 
side chains of cysteine residues are particularly susceptible to redox modifications and cysteine residues are 
attracting increasing research attention. However, protein oxidation processes are very complex and redox 
proteomics encompassess the full spectrum of PTMs induced by radicals. These can be divided into 
modifications that alter side chains of amino acids, and modifications altering protein backbones, causing 
fragmentation and cross-linking [87]. Moreover, non-protein components of cells like nucleic acids, lipids or 
carbohydrates activated by interaction with reactive species may react with a protein, which further extends the 
variability of the redox proteome [88, 89]. Here, we focus on cysteine oxidative PTMs, methionine oxidation, 
protein nitration and carbonylation. Protein glycation and protein deamidation are discussed in separate chapters. 
        
3.2.1. Cysteine oxidative modifications 
The amino acid that is the most common site of known PTMs is cysteine (Fig. 1). Its oxidative PTMs are 
commonly involved in redox signaling and reactive thiol side chains can act as sensors or switches in both signal 
transduction and enzyme regulation [90]. Depending on their local concentrations, ROS/RNS can react with 
cysteine to form several reversible or irreversible modifications (Fig. 5, C). Cysteine oxidative modifications are 
probably the best characterized redox PTMs to date, and a dedicated database of experimentally verified protein 
oxidative modifications (RedoxDB) has been established [91]. 
 
3.2.1.1. Visualization of modified cysteine residues 
The abundance of cysteine in proteins hinders direct detection of modified residues by in vivo [35S]cysteine 
radiolabeling. Several approaches for studying protein glutathionylation involving inhibition of protein 
biosynthesis and incorporation of radiolabeled cysteine into glutathione [92] have been developed, but they 
severely disrupt cell homeostasis. However, combining protein extraction with thiol (radio)labeling in vitro is 
feasible. The easiest method available for detecting disulfide bonds is by electrophoretic diagonal separation 
under first nonreducing and then reducing conditions (see Fig. 3, D). In principle, further disulfide labeling is not 
essential, but the sensitivity of the procedure is increased. All reversibly oxidized protein thiols can be switched 
to labeled thiols [93], as follows. First, the background labeling of unmodified cysteine residues is minimized by 
blocking free thiols using thiol-specific reagents such as maleimides, iodoacetic acid or iodoacetamide. Oxidized 
thiols are then reduced using modification-appropriate agents (e.g. ascorbate for nitrosylation, arsenite for 
sulfenylation, hydroxylamine for acylation, tris(2-carboxyethyl)phosphine for disulfides, and oxidoretuctase 
GRX treatment for glutathionylation), and the newly exposed thiols are simultaneously labeled with a thiol-
reactive biotin [92, 94]. The biotin switch method can be used for both enrichment and detection. Once the 
modified sites have been labeled with the stable biotin group, they can be easily detected by anti-biotin 
immunoblotting, or enriched by streptavidin affinity chromatography. Alternatively to biotin replacement, 
reduced cysteine residues can be labeled with a fluorescent dye (redox florescence switching), then readily 
separated and visualized using 2-DE (particularly the variant DIGE, difference gel electrophoresis, which allows 
the resolution of several differentially labeled samples in a single 2D-PAGE experiment). Proteins are labeled by 
Cy3 and Cy5 fluorescent dyes, which have a maleimide group that forms a thioether bond with the free thiols of 
cysteines in proteins. Comparison of gels stained with these dyes and a total protein stain (e.g. Sypro Ruby) 
provides exact quantitative and qualitative information about cysteine PTMs in analyzed sample [95]). Some 
cysteine PTMs can be also detected by specific antibodies. Antibodies have been raised against S-
glutathionylated proteins, sulfenic and sulfonic acid PTMs. However, their use has been limited to targeting and 
assaying the modification status of individual proteins, and they have not yet been used in any published large-
scale proteomic analysis [94, 96, 97].  
 
3.2.1.2. Enrichment of proteins containing modified cysteine residues 
The instability of redox cysteine PTMs often poses experimental challenges and thiol-disulfide exchange 
between proteins during isolation/enrichment steps may lead to misinterpretation of results. Hence, it is 
important to minimize changes in the thioldisulfide status of samples (e.g. alkylation of free cysteine residues) 
during enrichment steps. The alkylation followed by a “biotin switch” method described above is currently the 
most commonly used technique for purifying S-nitrosylated proteins and can be applied for analyzing any class 
of cysteine oxidative PTM for which a suitable reducing agent is available. However, the specificity of reducing 
agents is also a limiting factor here. It has been argued that even the selectivity of the ascorbate method for S-
nitrosylation might be compromised by ascorbate-mediated reduction of disulfides [98]. On the other hand, this 
technique is well established and various useful modifications have been developed. For example, Foresetre et 
al. replaced the biotin tagging with fast simultaneous labeling and capture using dipyridyl disulfide coupled to a 
resin, which can be followed by direct on-resin digestion and LC-MS/MS analysis [99]. This approach is similar 
to activated thiol sepharose chromatography, where the pyridyldithiol group is the moiety that reacts with 
reduced thiol groups and binds them. However, the binding efficiency of thiol sepharose for different proteins 
may vary, and this method has yet to be further validated [98]. Proteins with reactive disulfides can also be 
efficiently trapped by thioredoxin (Trx) affinity chromatography. Natural Trx has two cysteine residues in its 
active center, the first catalyzing formation of a mixed disulfide intermediate between Trx and its substrate, and 
the second cleavage of this short-lived bond by a nucleophilic attack. If the second cysteine residue is replaced 
by serine, the mutated Trx can be used to capture the disulfide proteome, and bound proteins can be 
subsequently released by treatment with dithiothreitol [100]. Some proteins can bind to Trx noncovalently in a 
protein-protein interaction manner, but this can be circumvented by collecting Trx-protein complexes and 
resolving them by nonreducing/reducing diagonal electrophoresis [101]. Trx-based enrichment is specific for Trx 
substrates, but not all disulfides are accessible to Trx and affinities may differ even among those that do bind 
[98, 100]. Thus, Trx affinity chromatography is not considered suitable for global redox-proteomics experiments. 
 
Glutathionylation results in PTMs that are relatively stable, compared to other oxidative PTMs, and in addition 
to the “biotin switch” method they can be targeted by specific antibodies, or by supplying a biotin-labeled 
glutathione ester to investigated cells [102, 103]. Proteins that be potentially glutathionylated can also be 
captured with agarose-bound glutathione [104], but this method does not help in monitoring the redox status of a 
cell. The latest promising strategy is on the border between protein- and peptide-based analyses. It employs two 
different alkylation agents, the first to protect free thiols prior to SDS-PAGE protein separation, and the second 
after oxidized cysteine in-gel reduction. Proteins are subsequently digested in-gel and peptides are subjected to 
16O/18O-labeling to differentiate controls and oxidized samples. Peptide-based comparison is then used for 
simultaneous analysis of dynamic alterations in the redox state of cysteine sites and protein abundance [105]. 
However, to address low-abundance proteins, this technique has to be combined with further enrichment steps. 
 
3.2.2. Tyrosine and tryptophan nitration 
Reactive nitrogen species are generated in various physiological processes, including mammalian inflammatory 
responses. The most common products of protein nitration are nitrotyrosine, and to a much lesser extent, 
nitrotryptophan (Fig. 5, B)[106]. Nitrotyrosine can be produced from the reaction between tyrosine and a strong 
nitrating agent like peroxynitrite and it is considered a general biomarker of disease progression [107]. In low 
complexity samples, nitrotyrosine can be traced by UV-Vis photometry. Like tyrosine, it has an absorption peak 
at 280 nm, but nitrotyrosine exhibits additional absorption peaks at ~ 357 and ~ 430 nm in acidic and basic 
solutions, respectively. Yang et al. (2010) exploited this technique to follow the kinetics of protein nitration by 
coupling HPLC with photo-diode array detection [108]. Similarly, nitrotryptophan formation can be detected by 
spectrophotometry. Tryptophan exhibits the strongest fluorescence of any proteinaceous amino acid, with an 
excitation maximum at 280 nm and an emission maximum between 305 nm and 355 nm, and its nitration leads 
to fluorescence quenching. Both nitrotyrosine and nitrotryptophan can be detected and/or enriched using specific 
antibodies [109] or derivatized. The derivatization method involves blocking all primary amines, reducing nitro-
residues to their amino- counterparts and selectively attaching an affinity handle (e.g. biotin) for enrichment or a 
reporter group for selective mass spectrometric detection [106, 110]. 
 
3.2.3. Methionine oxidation 
Like cysteine, the other proteinaceous sulfur-containing amino acid (methionine) is also readily oxidized, usually 
yielding methionine sulfoxide and methionine sulfone (Fig. 5, D). Sulfoxide formation can be enzymatically 
reversed by the action of specific reductases and it has been suggested that methionine could serve as an 
antioxidant that protects other amino acid residues from more deleterious damage [111]. While this possibility 
cannot be excluded, it has been shown that methionine oxidation can result in loss of a protein function or 
interference with other PTMs close to the oxidized site [112, 113]. Although methionine oxidation is detected in 
biological samples relatively often, thorough proteomic methodology for its characterization is still in 
development. Anti-methionine sulfoxide antibodies have been raised against oxidized methionine-rich zein 
protein [114], but a recent report indicates that their specificity is questionable [115]. Thus, it seems that the only 
robust options for analyzing oxidized methionine are peptide-based approaches, which can be based on the 16-
Da mass increase upon oxidation [116]. An advanced peptide-based method is diagonal chromatography (see 
section 2.2.5.), with enzymatic reduction of methionine sulfoxides by methionine sulfoxide reductase [117]. This 
method has been used to identify 35 in vivo methionine oxidations in the mouse serum proteome and could 
perhaps also be adapted for protein-level analyses.  
 
 3.2.4. Protein carbonylation 
Carbonylation is considered to be the third most common oxidative PTM, after cysteine and methionine 
oxidation. Direct protein carbonylation predominantly affects side chains of lysine, arginine, proline and 
threonine residues [118]. These oxidations are believed to be irreversible and result in glutamic semialdehyde 
(arginine and proline), 2-amino-3-ketobutyric acid (threonine) or aminoadipic semialdehyde (lysine) (Fig. 5, G) 
[119-122]. Indirect protein carbonylation is more prevalent and involves a reaction with oxidized AGE 
(advanced glycation end) products (described in glycoproteomics, section 3.4), or hydroxyl radical-mediated 
oxidation of lipids. Lipid-derived aldehydes can form Michael adducts with cysteine, histidine, lysine and 
arginine, and in some cases can further undergo Schiff base formation with amines of adjacent lysines, 
producing cross-linked amino acids[120, 123, 124]. Analysis of the resulting PTM diversity is hindered by their 
instability because carbonyl groups readily undergo Schiff base formation with proximate lysine residues, even 
when stored at -80 °C [122].   
 
3.2.4.1. Isolation and detection of carbonylated proteins 
To date, 2-DE analysis has been used in most proteomic studies of protein carbonylation [125]. For detection, 
reactive carbonyls can be reduced by [3H]sodium borohydride to corresponding tritium labeled alcohols, but 
most methods rely on covalent labeling with nucleophilic hydrazide- or hydrazine- based probes [126]. 
Originally a qualitative analytical method used in organic chemistry, based on the formation of nitrogen-carbon 
bonds (hydrazone) between carbonyls and dinitrophenylhydrazine (DNPH) was adapted to enhance the isolation, 
identification and quantification of carbonyl-containing proteins. In this approach, derivatized proteins are 
detected/captured by DNPH-targeting antibodies [120, 127]. DNPH can also reportedly react with thioaldehyde 
derived from sulfenic acid [128], but no enrichment of corresponding methionine or tryptophan oxidation 
products has been observed as yet [125]. Biotin-based hydrazides can be used instead of DNPH and derivatized 
proteins are then captured by biotin-avidin affinity chromatography (e.g. [125, 129]). However, the binding 
efficiency of biotin-based tags seems to vary considerably, and the most commonly used (biotin hydrazide) gives 
the lowest yield [130]. Carbonylated peptides have been successfully enriched by derivatization with Girard’s P 
reagent, which forms hydrazones with peptide carbonyl groups and contains a quaternary amine group that is 
selectable by SCX chromatography [131]. However, this methodology is unlikely to achieve comparable utility 
in analysis of intact proteins mainly because of, in general, modest influence of the newly generated positive 
charge on net charge of the respective protein. 
     
3.2.5. Troublesome path of redox proteomics 
Unfortunately, current experimental approaches are not able to deal robustly with the diverse spectrum of PTMs 
introduced by reactive species. While we are capable of detecting abundant PTMs, using 2-DE and mass 
spectrometry, for instance, targeted detection and enrichment techniques are available only for specific types of 
redox PTMs. Further, it might be difficult to distinguish between biologically relevant PTMs and artifacts 
introduced during an analysis. For example, tryptophan oxidation is considered to be a natural irreversible PTM, 
but it has been recently found that kynurenine and N-formyl kynurenine tryptophan oxidation products can be 
introduced into a protein during SDS-PAGE separation [132].  
 
3.3. Protein lipidation  
Covalent attachment of lipids controls the subcellular localization and activity of diverse proteins. The most 
common lipidation processes are prenylation, acylation and glycosyl phosphatidylinositol anchor (GPI) 
attachment (Fig. 5, E) [1, 133-135]. Farnesyl and geranylgeranyl-pyrophosphate molecules can be utilized as 
electrophilic alkyl donors in posttranslational protein prenylation of conserved cysteine residues at or near the C-
terminus of proteins. These PTM types, which were first reported in 1984 [136], are catalyzed by farnesyl 
transferase or geranylgeranyl transferase at the conserved sequence Cys-a-a-X (where a is an alifatic residue and 
X any residue), and have been shown to have profound effects on a host of processes involving signal 
transduction and intracellular trafficking [137-139]. Protein acylation classes of lipidation PTMs include N-
myristoylation at N-terminal glycine residues and S-acylation of cysteine residues by addition of palmitic acid or 
other long chain fatty acids. The latter is an important mechanism for dynamic targeting of proteins to 
membranes, and the labile, reversible thioester linkages are enzymatically formed and cleaved by 
acyltransferases and protein thioesterases, respectively [135, 140]. Non-enzymatic S-acylations are also possible, 
but apart from modifications reported in mitochondria, these reactions probably occur only in vitro [141]. N-
myristoylation is a cotranslational modification catalyzed by N-myristoyltransferases at the conserved sequence 
Gly-X-X-X-(Ser/Thr/Cys) after cotranslational hydrolysis of the Met1–Gly2 bond by methionine aminopeptidase. 
However, it can occur posttranslationally if an internal glycine residue is exposed upon protease-catalyzed 
cleavage [1, 135]. Attachment of GPI (which consists of a phosphoethanolamine linker, a glycan core, and 
phosphatidyl inositol tail) at the C-terminus of a eukaryotic protein results in its plasma membrane localization 
[142]. Other lipid PTMs, including O-acylation and C-cholesterylation, have been reported, but they do not seem 
to be widespread [143, 144].  
 
3.3.1. Analysis of protein lipidation  
Attachment of a lipid moiety increases a protein’s hydrophobicity, which restricts the methods that can be used 
to separate lipidated proteins. Unless lipid PTMs are removed, the best methods for resolving lipidated 
proteomes are multidimensional liquid chromatography or BN-PAGE. However, if the aim of an analysis is 
solely to identify proteins undergoing lipidation, they can be enriched then released by enzymatic or chemical 
cleavage. For example, GPI-modified membrane anchored proteins can be enriched from soluble proteins by 
Triton X-114 partitioning [145], as they separate into the micelles fraction with other membrane-associated 
proteins. Subsequent cleavage of the GPI anchors by phosphatidylinositol-specific phospholipase C releases 
these proteins into the soluble fraction, from which they can be separated by repeated Triton partitioning. 
However, this technique does not provide information about GPI composition, or sites of GPI attachment in the 
proteins. Moreover, some GPI-anchored proteins are phospholipase-insensitive due to lipid remodeling within 
the GPI anchor [146]. However, GPI contains glucosamine, which is generally rare in other glycoproteins. Thus, 
instead of enzymatic cleavage, nitrous acid deamination can be used to break the glycosidic bond between 
glucosamine and the myo-inositol ring, resulting in cleavage of the lipid portion of the GPI anchor [147].  
 
3.3.2. Detection and enrichment of lipidated proteins  
Like the first methods for detecting most of the long-known protein PTMs, the first methods for detecting 
protein lipidation were based on radiolabeling, more specifically feeding [3H] and [125I]-labeled fatty acids, 
followed by protein separation and autoradiography. This is still one of the methods of choice for confirming the 
presence of a lipid moiety in a protein since it is not based on indirect detection [135, 138]. In addition, due to 
the paucity of lipid antigenicity relatively few antibodies that recognize specific lipids have been described 
[148]. Antibodies for specific GPIs are known (e.g. the immune response to malaria involves the production of 
anti-GPI antibodies that recognize the unique plasmodium glycan modifications in the Plasmodium falciparum 
GPI anchor), but it remains to be shown if any anti-lipid antibodies could be applied for large-scale protein 
lipidation analyses. The “Biotin-switch” method described above for cysteine PTMs (see section 3.2.1) has been 
successfully applied for detecting S-acylation (with hydroxylamine as a reducing agent), but there are no reports 
of a modified version for detecting other types of protein lipidation PTMs. Instead, a new approach has emerged, 
based on metabolic labeling with lipid analogs containing chemical groups that are not present in biological 
samples. These chemical groups, e.g. alkyne or azide, can be then targeted either in vitro or in vivo by 
“bioorthogonal” chemical reactions, such as Staudinger ligation [149] or copper-catalyzed azide-alkyne 
cycloaddition (CuAAC) [150, 151]. However, as detection systems these chemical reporters are several orders of 
magnitude less sensitive than antibody-based systems, and the high concentrations of reactants that would 
perturb cellular homeostasis severely limits application of this strategy in vivo [152]. Nevertheless, azide- and 
alkyne-functionalized lipid chemical reporters have already allowed tremendous advances in the detection of 
protein S-acylation [153-155], N-myristoylation [156] and prenylation [157]. After protein extraction, the 
chemical reporters are reacted with fluorescent or biotinylated tags for in-gel detection or avidin-biotin 
enrichment, respectively [135, 158]. The major drawbacks of this technique are the necessity of metabolic 
labeling, which means that it cannot be applied to characterize standard samples, and the possibility that the 
unnatural substrates used may be processed by cell enzymes in different ways from natural counterparts. Further, 
for efficient labeling of prenylated proteins prior to prenylome profiling, the endogenous isoprenoid pool has to 
be depleted with statins, which precludes comparative studies of different cellular states and analysis of 
regulatory mechanisms without significant metabolic perturbation of cells [159]. An alternative to bioorthogonal 
reactions is in vitro labeling, which requires use of engineered enzymes with modified substrate specificity, e.g. 
a protein prenyltransferase with biotin-geranylpyrophosphate specificity for prenylome analysis [160]. Such a 
modified enzyme can be also introduced into cells, but the technique is better suited for in vitro detection of 
potential protein lipidation targets.  
 
3.4. Glycoproteomics 
In 1857 the French physiologist Claude Bernard described “glycogenous matter” in liver as a storage form of 
glucose. The possible existence of a protein component of glycogen was reported just three decades later, but its 
presence was only accepted after nearly a century of further research. Nevertheless, we can consider glycogen, 
with its protein core glycogenin, to be the first studied glycoprotein [161, 162]. Today, we know that proteins 
can undergo covalent modification by carbohydrates via non-enzymatic glycation or enzymatic N-glycosylation, 
O-glycosylation and C-glycosylation (Fig. 5, H). These PTMs play important roles in many key biological 
processes, including protein folding, signaling, enzymatic activity, molecular trafficking, cell adhesion and 
protein turnover [163, 164]. Glycosylation is believed to be more prevalent than phosphorylation and it is 
estimated that at least 50 % of all proteins are modified by carbohydrates [163]. N-linked glycosylation is by far 
the most thoroughly studied form of carbohydrate PTM. It predominantly involves cotranslational attachment of 
a glycosyl moiety to the carboxamide nitrogen atoms of asparagine, almost always in the consensus sequence 
Asn-X-Ser/Thr (where X is any amino acid residue except proline), by N-glycosyltransferases in the lumen of 
the endoplasmic reticulum and Golgi apparatus [165]. O-glycosylation has been frequently documented at serine 
and threonine residues, less frequently at hydroxyproline and hydroxylysine sites, and very rarely at tyrosine 
sites. The glycosyl moieties involved are generally shorter and less complex than N-glycosyl moieties, which 
may make it more suitable for reversible regulation by specific transferases and hydrolases. In further contrast to 
N- glycosylation, there is no known conserved sequence motif for O-glycosylation [1, 164]. C-glycosylation is 
rare, and has only been found at tryptophan residues, the C2 position of the indole ring being a mannosylation 
target [163]. Non-enzymatic protein glycation may occur at lysine or arginine amino groups, or the N-terminal 
amino acid residues of proteins. In the process, the aldehyde group of the open chain of a reducing sugar 
condenses with an amino group to form a Shiff base, and then an Amadori rearrangement of the double bond to 
the C2 of the sugar occurs, yielding a stable, covalently linked ketoamine compound (early glycation product 
This process may slowly and spontaneously revert, thereby regenerating the free sugar and the amine, or the 
glyco-portion may undergo a further series of reactions leading to the formation of various heterogeneous 
structures commonly known as advanced glycation end-products (AGE) [166]. 
 
The attachment of sugar residues can generate greater structural diversity than any other kind of protein PTM. 
While three different amino acids can theoretically generate six different peptide-bond trimers, three different 
hexoses could produce anywhere from 1,056 to 27,648 unique trisaccharides; a massive difference [162]. In 
nature, the sheer number of combinations is limited by the specificity of glycosyltransferases, but the diversity of 
mature glycan chains is still considerable and the remarkable variation in the attached oligosaccharide chains is 
the major obstacle in glycoproteomics. For this reason, large-scale analyses have typically focused either on 
characterization of the protein parts and mapping the PTM sites, or characterization of the glycan structures. The 
latter is beyond the scope of this review and for more information the reader is referred elsewhere, e.g. the 
excellent tutorial by An and Lebrilla (2011)[167]. Here, we focus on general approaches to detect and enrich 
glycoproteins from a complex sample. 
 
3.4.1. Visualizing a glycoproteome 
Detection of carbohydrate protein PTMs can be facilitated by metabolite labeling with either radioactive or 
chemically derivatized monosaccharides. In vivo treatment with [3H]- or [14C]-labeled glycan precursors 
followed by electrophoretic separation allows autoradiographic detection of any glycoprotein into which they are 
incorporated [168]. Alternatively, cells can be fed a bioorthogonal chemical tag, usually an azido analog, that 
allows chemoselective ligation and hence specific enrichment or detection of glycoconjugates in the same 
manner as described above for lipid conjugates [169]. Both of these approaches can be utilized in vitro for 
detecting potential glycosylation targets using recombinant glucosyltransferases, or for analyzing spontaneous 
non-enzymatic glycation, because the generation of early glycation products with proteins occurs at a rate 
proportional to the reducing sugar concentration. Glycoproteins resolved by 2-DE or SDS-PAGE can be 
visualized by specific staining, most classically by a periodic acid-Schiff stain (PAS) procedure, in which 
glycans’ vicinal diols are oxidized to aldehydes then reacted with Schiff reagent, yielding pink to magenta 
adducts [170]. The detection limit is reportedly 25-100 ng for free carbohydrates, but the reported sensitivity for 
glycoproteins is in the range 1-10 g [171]. Sensitivity has been slightly improved by combining the PAS 
reaction with alcian blue or dansyl chloride staining, or by tagging periodate-oxidized aldehydes with biotin 
hydrazide and detecting the biotin (by streptavidin-bound peroxidase for instance), but these labeling procedures 
are seldom utilized in practice [171-173]. The fluorescent dye Pro-Q Emerald (Life Technologies) also reacts 
with periodic acid-oxidized carbohydrate groups, but the protocols are more rapid than previously mentioned 
PAS-based labeling procedures and reportedly at least 50-fold more sensitive [174]. Similar alternatives have 
been produced, for example by Sigma (Glycoprofile III fluorescent kit; discontinued) and Pierce (Krypton 
Glycoprotein staining kit) [172]. Specific protein glycosylation PTMs can be detected after electrophoretic 
separation by Western blotting using glycan-specific antibodies, or overlays with radio-labeled or enzyme-
conjugated lectins. Lectins are natural proteins characterized by their ability to selectively bind carbohydrate 
ligands. Most lectins bind reversibly, do not modify carbohydrate covalent structures, and are non-immune in 
origin [175]. Hundreds of lectins have been described and more than 60 are commercially available, with 
specificity ranging from very broad (e.g. Concanavalin A binds N-glycoproteins by recognizing a shared 
trimannosyl motif of the N-glycan core structure) to very narrow (e.g. Sambucus nigra lectin is specific for sialic 
acid attached to galactose/N-acetylgalactosamine by an ( 2-6) linkage [176](See Tab. 1). Lectin-based detection 
is also employed in so-called “lectin microarrays”, in which discreet fractions of a proteome are usually spotted 
onto nitrocellulose substrates and the resulting array is subsequently incubated with a specific lectin. An 
alternative antibody-lectin sandwich version captures specific glycoproteins by antibodies and hybridized arrays 
are then incubated with fluorescently or biotin-labeled lectins for detection. This approach is primarily used for 
detecting and comparing differences in glycan structures, but MS can be used to identify the glycoproteins 
within a sample [177-179]. Glycoproteins may also be detected by mobility shifts, in either the pI or MW 
dimension, in diagonal separations after enzymatic or chemical (e.g. trifluoromethanesulphonic acid-induced) 
cleavage of glycosylation bonds [29, 180]. 
 
<-Table 1-> 
 
3.4.2. Enrichment of glycosylated or glycated proteins 
Methods described for glycoprotein detection, including metabolite labeling, hydrazide reaction with oxidized 
carbohydrates, and especially lectin-based procedures, have also been used to enrich glycoproteins. Lectin 
affinity chromatography can be used with single lectin species, or multiple lectins to capture (for example) all N-
linked glycoproteins [165, 181, 182]. Depending on the lectin(s) used, binding may require the presence of metal 
ions or a specific pH. Bound glycoproteins are then desorbed by using a chelating agent or lowering the pH, 
respectively, but this can of course be facilitated by simply adding a high concentration of the free carbohydrate 
ligand(s). Hydrazide coupling is the major chemical-based enrichment technique for glycoproteomic analysis. 
The coupling reagent can be either linked to biotin and captured via biotin-avidin affinity, or immobilized on 
beads [183, 184]. Similar chemistry has also been used for more specific enrichment. For example, Zeng et al. 
(2009) introduced a method for the selective derivatization of sialic acid by mild periodic oxidation and ligation 
with an aminooxy tag in the presence of aniline, and the same group has recently described an approach to 
specifically enrich glycoproteins with terminal N-acetylgalactosamine/galactose [185, 186].  
 
Lectin- or hydrazide/aminooxy-bound glycoproteins can be digested on-beads and the remaining glycan-
containing peptide(s) can be released and, if desired, various tags can be incorporated into them for quantitative 
purposes [184, 187, 188]. This is suitable for analysis of N-glycans because the known enzyme N-glycosidase F 
cleaves the glycosidic bond between the asparagine residue of a glycosylated protein and the core N-
acetylgalactosamine, thereby liberating nearly all N-linked glycans. This is a particularly attractive reaction, 
because it results in deamidation of asparagine to aspartate with a mass shift of 1 Da (or 3 Da in [18O] water) 
which is indicative of a PTM site and can be used for comparative quantitation. However, it should be mentioned 
that spontaneous deamidation (see section 3.5) has the same effect and may lead to erroneous assignments [189]. 
A lack of broad-specificity O-glycosidases can be circumvented by reductive -elimination through the use of a 
strong base [190] or hydrazinolysis [191], both of which release O- and N-linked glycopeptides. Another method 
for glycoproteome enrichment is based on the reversible reaction of boronic acid with 1,2-cis-diols [192]. These 
moieties are present in glycan components like mannose, galactose, glucose, and sialic acid, but are also 
preserved in glycated proteins, and boronate affinity chromatography is currently the only antibody-independent 
method for enriching glycated proteins [166, 193]. Several derivatives of boronic acid have been introduced for 
this purpose, including bisboronic compounds, which can also be conjugated with a fluorescence tag and used 
for detecting protein glycosylation/glycation [194], and both sulfonyl- and sulfonamide-phenylboronic acid 
derivatives, which can be used at physiological pH. These adjustments have solved the major drawback of the 
original setup; the need to use alkaline buffers due to the relatively low ionization constants of the commonly 
used phenylboronic acid ligands [195]. Non-specific boronate affinity has also been successfully combined with 
lectin affinity in boronic acid-lectin affinity chromatography [196]. In addition, boronate in the form of 
methacrylamido phenylboronic acid has been copolymerized in acrylamide gel and applied to detect, analyze and 
separate early and AGE glycation products from unaffected proteins [197]. During the electrophoretic 
separation, migration of glycated proteins is hindered and gel resolution allows various carbohydrate-protein 
adducts to be distinguished. A boronate gel was commercialized by Pierce (Glycogel II boronate affinity gel), 
but it is no longer available. Anti-glycosylated/glycated protein antibodies have also been employed in Western 
blot analyses, and can be used for specific enrichments. This is especially useful for analyzing protein glycations 
that are not recognized by lectins and a number of antibodies have been prepared for analyses of AGE protein 
modifications, notably for detecting -N-carboxymethyllysine and -N-carboxyethyllysine [198, 199]. These can 
be raised, for example, against bovine serum albumin that has been treated with glycolaldehyde, and are 
commercially available (e.g. Millipore; http://www.millipore.com). 
 
3.5. Protein deamidation 
Asparagine and glutamine residues in both proteins and peptides can be deamidated through spontaneous 
chemical reactions that may occur either in vivo or in vitro. The rates of deamidation depend (inter alia) on pH, 
temperature and protein structure. Depending on the surrounding amino acids, half-times of deamidations of 
specific asparagine and glutamine residues in proteins are within ranges of 1-500 days and 100-1000 days, 
respectively, at neutral pH and 37 °C [200]. The rates are significantly higher at alkaline pH, which is typical 
(for instance) in trypsin digestion. Thus, it is difficult to distinguish a natural protein deamidation, which could 
be a marker of a disease or protein ageing, from artifactual deamidation during proteomic sample preparation 
[201, 202]. Deamidation proceeds via formation of a cyclic intermediate by condensation of the side-chain amide 
group with the carbonyl group of the following amino acid, and subsequent opening of this ring upon hydrolysis 
with water. While this process cannot be completely avoided, even with an improved protocol [202], a potential 
way to discriminate in vitro reactions is to prepare samples in [18O]-water, which increases the molecular weight 
of deamidation artifacts [203, 204]. The hydrolysis of a ring intermediate can yield two products; aspartic acid 
and isoaspartic acid in the case of asparagine (Fig. 5, I). The second product is more frequent (yield up to 70 %) 
and leads to a significant change in the backbone structure of the host protein. Thus it is often accompanied by a 
loss of biological activity. Deamidation also introduces an additional negative charge in the protein and can be 
detected by charge-sensitive separation methods (IEF, 2-DE or ion-exchange chromatography) [205, 206]). 
Isoaspartyl residues can be enzymatically converted to asparagyl residues by protein L-isoaspartyl O-
methyltransferase [207], which can be used to label proteins containing isoaspartyl residues by [3H]-methylation 
in vitro. Proteins can then be separated (e.g. by 2-DE) and converted isoaspartyl residues can be detected by 
autoradiography [206, 207]. There is no specific enrichment procedure for isolating a deamidation proteome, and 
large-scale analyses thus depend on advances in mass spectrometry [208, 209]. 
 
3.6. Protein acetylation 
Acetylation of proteins is a specific form of protein acylation (Fig. 5, E) that was discovered in the early 1960s 
[210-212]. The most common types are N-acetylation of the amino terminus of a protein and N-acetylation of 
lysine residue side chains, but O-acetylations of serine and threonine have also been reported [213]. N-terminal 
acetylation rarely occurs in prokaryotes, but it occurs in about 50 % of yeast proteins and more than 80 % of 
human proteins [214, 215]. It is believed to be irreversible and Hwang et al. found that it could act as a signal for 
ubiquitin-dependent degradation [216]. -Lysine acetylation is by far the most extensively studied form of 
acetylation. It is regulated by N-acetyltransferase and deacetylase enzymes, and plays roles in protein stability, 
localization, enzyme activity, and (in histone acetylation) directly regulates gene expression by changing 
chromatin structure [217-219]. Analysis of the acetylome is hindered by the high abundance of acetylated 
histones in the cell and the lack of suitable physical and biochemical properties of the acetyl group that could be 
exploited for its specific enrichment. However, acetylation masks positive charges of lysine residues (or N-
termini) and can thus be detected by changes in proteins’ pI (IEF, 2-DE) [220]. There has also been some 
success in the development of anti-acetyllysine antibodies and immunoaffinity enrichment techniques [221-224]. 
However, Shaw et al. clearly demonstrated the limitations of this strategy by showing that sets of acetylated 
peptides detected by a cocktail of monoclonal antibodies raised against acetylated lysine in different sequence 
contexts differed from those detected by the polyclonal antibodies used by other groups [225]. Acetylome 
analyses could benefit from diagonal separation, but the only such technique reported to date is a chemical-based 
combined fractional diagonal chromatography (COFRADIC) approach to determine N-terminal acetylation 
[226], and no method employing enzymatic deacetylation has been presented as yet. 
  
3.7. Protein methylation 
The first report on the occurrence of a methyl PTM in a protein dates back to 1959, when Ambler and Rees 
found -N-methyl-lysine in a bacterial flagellar protein [227]. Protein methylation predominantly occurs at lysine 
and arginine residues, but N- or O-methylation has also been detected at side chains of other amino acids, N-
terminal amino groups and C-terminal carboxyl groups. There have even been reports of cysteine S-methylation 
and C-methylation at methylene carbons of arginine and glutamine (Fig. 5, F) [1, 228, 229]. Methylation affects 
proteins’ hydrophobicity and can mask a negative charge (by formation of methyl esters). It has demonstrated 
roles in various processes, e.g. signal transduction, mRNA splicing, transcriptional control, DNA repair, protein-
protein interactions, protein stability and protein translocation [229, 230]. Methylation is often catalyzed by 
methyltransferase enzymes that utilize S-adenosylmethionine as a substrate, but S-adenosylmethionine can also 
readily methylate cysteine and histidine residues non-enzymatically in vitro, and a similar non-enzymatic 
mechanism has been proposed for the methylation of some proteins in vivo, e.g. human lens crystallins [231]. It 
was long believed that N-methylation is irreversible and that reversibility of O-methylation is due to spontaneous 
non-enzymatic decomposition of the ester bond. However, this view was changed by the discovery of lysine 
demethylases [232] and the search for arginine demethylases is in progress [233].  
 
3.7.1. Protein methylation detection and enrichment of protein methylomes 
The methylation of eukaryotic proteins may be widespread, but the large-scale proteomic techniques that could 
rigorously test this hypothesis are just emerging. Protein methylation can be detected by metabolite labeling 
using [14C]- or [3H]-radiolabeled S-adenosylmethionine, followed by protein extraction, separation and 
autoradiography, but to date this procedure has been limited to small-scale analyses and in vitro detection of 
possible substrates of methyltransferases [234, 235]. Anti-methyllysine and anti-methylarginine antibodies have 
been raised and successfully employed in methylated protein enrichment and Western blot detection [235, 236]. 
The subtle chemical differences, e.g. between methylated and unmodified arginine, limits the application of 
antibodies for intact protein enrichment. However, using antibodies in combination with stable isotope labeling 
by amino acids in cell culture (SILAC) by [13CD3]methionine, Ong et al. detected 59 methylation sites in HeLa 
cell extracts [235]. In addition, Uhlmann et al. recently reported a peptide-based method for large-scale 
identification of protein arginine methylation that seems to outperform antibody-based enrichment [237]. They 
detected 249 methylation sites in peptides from a SILAC-labeled cell lysate and showed that most arginine 
methylated peptides were highly basic and hydrophilic, which facilitated their purification. A comparison of the 
effectiveness of SCX chromatography, IEF and hydrophilic interaction liquid chromatography (HILIC) clearly 
indicated that HILIC [238] is by far the most effective for this purpose. Surprisingly, however, Uhlmann et al. 
have not found a similar level of enrichment for peptides containing methylated lysine [237]. 
 
3.8. Protein ubiquitination  
Ubiquitin is a highly conserved protein of about 8.5 kDa, which can be attached in an ATP-dependent manner to 
a protein. The history of protein ubiquitination research dates back to 1977, when Goldknopf and Busch 
described an isopeptide bond between a histone 2A lysine residue and the tryptic C-terminal diglycine remnant 
of a different protein [239]. PTM by ubiquitin and ubiquitin-like proteins represents a major regulatory system. 
The basic enzymatic cascade couples the C-terminus of ubiquitin via an isopeptide bond to the -amino group of 
lysine residues on substrate proteins (Fig. 5, J) or, less frequently, via peptide bonds to the N-terminus, but 
evidence has also emerged for ubiquitin ester bonds via cysteine, serine or threonine residues [240]. Proteins can 
be monoubiquitinated, or polyubiquitin chains may form via linkages involving any of the molecule’s seven  
lysine residues (K6, K11, K27, K29, K33, K48, K63) or its N terminus, which have different structures and 
properties, depending on how the chains are assembled [241]. Protein (poly)ubiquitination is known to regulate 
protein turnover by influencing proteasome-mediated degradation, gene transcription, subcellular trafficking and 
protein localization, enzymatic activity, and to facilitate protein-protein interactions [242-246]. Ubiquitination is 
catalyzed through the sequential action of three discrete enzymes: the ubiquitin activating enzyme (E1), 
ubiquitin-conjugating enzyme (E2), and ubiquitin-ligating enzyme (E3). Ubiquitin tags can be removed or edited 
by deubiquitinating enzymes (DUBs). The number of enzymes involved rivals those involved in 
phosphoproteome regulation: the human genome encodes approximately 10 E1, 40 E2, over 600 E3 and 80-90 
DUBs. Plant signaling is highly dependent on ubiquitin, which is reflected in over 1,000 Arabidopsis thaliana 
genes for E3 [247, 248].  
 
3.8.1. Protein ubiquitination - enrichment 
The “ubiquitinome” poses several analytical challenges, including the fact that ubiquitination frequently leads to 
protein degradation and loss of modified proteins, unless the proteasome pathway is inhibited [249]. Previously, 
proteomic methods for ubiquitin enrichment have predominantly utilized affinity-tagged labeling and antibody-
based capture. Beers and Callis engineered a variant of ubiquitin containing a polyhistidine-tag at its N-terminus 
for an in vitro assay, which allowed IMAC enrichment of proteins with incorporated tagged ubiquitin [250]. A 
similar approach can also be used for in vivo analyses of transgenic lines expressing tagged ubiquitin [251, 252]. 
Non-specific binding can be circumvented by employing another specific label in addition to ubiquitin (e.g. 
biotin)[253], but this does not eliminate competition between the tagged exogenous ubiquitin and the 
endogenous wild-type molecule, which lowers the sensitivity of this method. Further, the possibility that added 
tags may influence the physiological activity of the molecule cannot be excluded [254]. Some natural proteins 
are known to associate with ubiquitin and their ubiquitin-binding domains have been used as agarose conjugates 
for ubiqitinome affinity enrichment [254]. This technique has been further developed by fusing domains into 
tandem-repeated ubiquitin-binding entities (TUBEs)[255], which reportedly have higher affinity for 
polyubiquitin chains and are capable of protecting ubiquitinated proteins from proteasome cleavage or enzymatic 
deubiquitylation, a process difficult to inactivate even in denaturating conditions [256]. Ubiquitinated proteins 
are routinely detected by Western blotting with anti-ubiquitin antibodies and antibodies have also been used with 
some success for ubiquitinome enrichment [257]. Antibody-based enrichment has also been applied in peptide-
based approaches for ubiquitination detection [258]. Trypsin proteolysis of a ubiquitin-conjugated protein 
produces a signature peptide for MS-based detection at the ubiquitination site containing a two-residue remnant 
(glycine-glycine) that is derived from the C terminus of ubiquitin and is still covalently attached to the target 
lysine residue via an isopeptide bond [251]. Antibodies raised against this sequence are effective tools for 
profiling ubiquitinated substrates and have significantly increased the number of verified proteins with 
ubiquitination PTMs [259]. 
  
4. Summary 
Difficulties associated with MS-based analysis have driven the development of alternative approaches to enrich 
and detect PTM modified proteins. Advances in MS-based proteomics have greatly facilitated the identification 
of thousands of PTM sites in eukaryotic cells and revealed novel modifications, but also shifted the focus of 
protein PTM analyses from a proteome to a peptide level. A key element for the success of these studies is the 
ability to enrich modified peptides using antibodies or other chemical approaches. This has worked reasonably 
well for O-phosphoproteome analysis, but most other PTMs have been more difficult to address and remain 
poorly characterized because of the lack of such enrichment methods. However, all known PTMs may be 
analyzed using the general workflow illustrated in Fig. 6. Indeed, if it was not for the low abundance of modified 
proteins, 2-DE and/or reversed-phase or HILIC chromatography would be sufficient to detect most known 
protein PTMs, due to the unsurpassed resolution of the former for pI/MW protein separation and the ability of 
the latter to recognize changes in protein/peptide hydrophobicity. As it stands, these methods only provide 
satisfactory results for abundant proteins or PTMs tagged with specific (radio)-labels. Sample labeling used to be 
an essential step for any PTM study and it still remains advantageous. Labels may be introduced by enzymatic or 
chemical reactions in vivo or during/after protein extraction. Labels not only facilitate detection, but can also be 
used for specific enrichment. The major drawbacks usually lie in reductions in yields when in vitro derivatization 
is applied, and/or the necessity to use enzymes with modified substrate specificity. Analyses of rare protein 
PTMs may be improved by proteome fractionation, immunodepletion or proteome equalization. While each 
additional protein isolation step provides indisputable benefits, they all prolong the procedure and usually 
compromise labile PTMs. Nevertheless, there has been substantial development in PTM enrichment 
methodology and a number of modifications may be addressed directly by (immuno)affinity enrichment. 
Enriched samples may be further processed (e.g. by 2-DE) or digested. This is the point where bottom-up and 
top-down proteomic approaches converge and may proceed through peptide-based enrichment, or directly to MS 
analysis. In recent years approaches for analyzing protein PTMs have rapidly developed, but large proportions of 
peaks in MS spectra of protein samples are still typically not assigned, and may originate from hidden PTMs. 
This hypothesis has been recently corroborated by the detection of a signature fragment of a novel O-
acetylglucosamine-6-phosphate PTM in a re-analysis of a large-scale proteomics dataset [260]. Thus, we are still 
clearly far from an optimal procedure for PTM analyses, and further advances are required not only in protein 
isolation and MS sensitivity, but also in bioinformatics. 
 
<-Figure 6-> 
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Primary Sugar Specificity Lectin 
Mannose Concanavalin A (ConA), Lens culinaris agglutinin (LCA), Lentil lectin (LCH), 
Snowdrop lectin (GNA), Phaseolus vulgaris leucoagglutinin (PHA-L), Pisum 
sativum agglutinin (PSA) 
Galactose Jacalin (AIL), Coral Tree (ECL), Griffonia simplicifolia lectin I (GSL I), Peanut 
Agglutinin (PNA) 
N-acetylgalactosamine Dolichos biflorus agglutinin (DBA), Soybean agglutinin (SBA), Sophora 
japonica agglutinin (SJA), Vicia villosa lectin (VVL) 
N-acetylglucosamine Datura stramonium lectin (DSL), Griffonia simplicifolia lectin II (GSL II), 
Lycopersicon esculentum lectin (LEL), Solanum tuberosum lectin (STL), Wheat 
germ agglutinin (WGA) 
Fucose Aleuria aurantia lectin (AAL), Ulex europaeus agglutinin (UEA),  
Sialic acid Elderberry lectin (SNA), Maackia amurensis lectin (MAL) 
Tab. 1 - Lectins commonly used in glycoproteomic analyses.  
 
Legends: 
Fig. 1 - Frequencies of 22 proteinogenic amino acids and their known PTMs. The percentages indicate 
amino acid usage in complete human (gray), model yeast (Saccharomyces cerevisiae, orange) and model plant 
(Arabidopsis thaliana, green) proteomes (i.e. the entire sets of proteins expressed by these organisms, according 
to information  retrieved from http://www.uniprot.org, 10/2012). The bottom part lists numbers of known 
naturally occurring PTMs at individual residues (RESID database; release 70.01). This plot illustrates the wide 
variability of protein PTMs, but not their amino acid ratios in the proteomes, which also depend on the relative 
abundance of the expressed proteins 
Fig. 2 - The loss of information in bottom-up proteomic analyses. It is widely accepted that a protein may be 
identified based on a single unique (proteotypic) peptide with a well-matched mass spectrum. However, while an 
identified fragment may represent a corresponding theoretical protein (A), alternatively it may be part of a 
spliced isoform or the result of protein degradation (B), or an indicator of  a PTM, especially if the missing 
sequence fulfills requirements for MS detection [2] (C).      
Fig. 3 - Essential methods for protein multi-dimensional separation. 
(A) Schematic workflow of 2-DE analysis. Proteins are separated and focused in the first dimension by IEF in a 
strip with a pH gradient according to their pI. The strip with focused proteins is then equilibrated with SDS 
buffer to form SDS-protein complexes and usually treated with a reducing agent (e.g. dithiotreitol) and 
iodoacetamide to reduce disulfide bridges and alkylate cysteine residues, respectively. The SDS-protein 
complexes are then separated in the second dimension by SDS-PAGE. (B) Detection of a protein PTM by 2-
DE. A subunit of chloroplastic ATP synthase was identified in three neighboring spots. The apparent molecular 
mass of the protein is 55 kDa, in accordance with the theoretical MW, 55.3 kDa. The comparison of apparent pI
values indicates that spot (3) represents unmodified protein, while the proteins in spots (2) and (1) bear 
modification(s) that lower their pI to more acidic values.  (C) Analysis by 2D-LC. Fractions from a first LC 
separation are collected and analyzed by a second LC with contrasting conditions and/or media. The resulting 2D 
map is based on UV-VIS profiles and its resolution, especially in the first dimension, is to some extent 
proportional to the number of collected fractions. (D) Diagonal separation. Classical separation and detection of 
inter- and intra-molecular disulfide bonds, as described in section 2.2.5. 
Fig. 4 - Depletion of major abundant proteins can uncover hidden PTMs. Demonstration of immunoaffinity 
depletion and proteome equalization in the Arabidopsis thaliana proteome resolved by 2-DE. A sample of 7-day-
old seedlings was divided into three aliquots. One was used for total (acetone/TCA) extraction (A), one was 
immuno-depleted of RuBisCO using a Seppro IgY RuBisCO depletion column (B) and one was equalized by 
CPLL ProteoMiner (C). Protein spots corresponding to RuBisCO subunits (53 kDa and 20 kDa), show that both 
B and C successfully depleted RuBisCO. Demonstration of CPLL effectiveness: Rectangle – no visible effect of 
highly abundant protein depletion; Circle – seven protein spots identified as RuBisCO activase; the wide ranges 
of pI and MW indicate intensive PTM regulation. Bio-Safe Coomassie stain, 150 g of protein, 7 cm IPG strip 
(based on [45]; and our unpublished data). 
Fig. 5 - Chemical structures of selected PTMs. Protein PTMs described in this review can be separated into 10
distinct but overlapping classes (indicated by colored frames). Individual classes may be further subdivided 
(dotted lines).  (A) Phosphorylations found in proteins. Ser, Thr and Tyr are amino acids that can be O-
phosphorylated; N-phosphates (amidates) are formed on residues of Lys, His and Arg; acetylphosphorylation is 
the least stable protein phosphorylation and has been documented only for Asp (Cys residues are phosphorylated 
as intermediates during the enzymatic catalysis, but as this bond is transient they are not usually regarded as 
protein PTMs). (B) Protein nitration is documented on Trp and Tyr with 6-nitrotryptophan and 3-nitrotyrosine 
being the major nitrated products [50]; Cys residues may be modified by S-nitrosylation. (C) Selected products 
of cysteine oxidation. Cysteine is known to undergo a number of oxidative PTMs. The selected PTMs represent 
only modifications of the Cys side chain, ignoring protein crosslinking and some less common PTMs that may 
occur, e.g. cystenylation (formation of a disulfide bridge between a protein cysteinyl residue and free cysteine) 
and thiosulfonate formation (Cys-S-SO2-Cys). (D) Products of methionine oxidation. (E) Protein acetylation 
and lipidation. Representatives of S-, O- and N-acylations, an example of a glycosyl phosphatidylinositol 
anchor, and a Cys/His/Lys/Arg bound product of lipid oxidation (advanced lipidation end-product), 4-hydroxy-
2-nonenal (which accounts for > 95% of the total unsaturated aldehydes produced during in vitro microsomal 
lipid peroxidation [51]); (F) Protein methylation. Representatives of Lys, Arg and His N-methylations; S-
methylation of Cys; C-methylation of Glu; and an example of a methyl ester. (G) Products of protein 
carbonylation. The direct oxidation of Arg and Pro (glutamic semialdehyde), Thr (2-amino-3-ketobutyric acid) 
and Lys (aminoadipic semialdehyde); examples of indirect protein carbonylation products after protein 
interaction with oxidized lipid or carbohydrate. (H) Protein glycosylation. The N-glycan core structure 
transferred to the conserved sequence Asn-X-Ser/Thr (where X represents any amino acid except Pro), and 
examples of: O-glycosylation, C-mannosylation of Try, an Amadori product of glucose and Lys interaction, and 
an AGE-product resulting from further conversion of N6-fructosamine lysyl and protein crosslinking. (I) 
Deamidation and production of an isopeptide bond. (J) Protein ubiquitination. An example of enzymatic 
monoubiquitination at Lys, this is essentially a form of protein acylation, but its distinguishing protein-protein 
nature demands a separate category.    
Fig. 6 - Schematic workflow for protein PTM analysis. 






